An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
Editorial by Βy Prof. Daniele Regge, Chief of the Radiology Unit, Candiolo Cancer Institute (FPO) The Clinical Vision of the project and added value for patients One man in eight is diagnosed with prostate cancer during his lifetime and among them, approximately one...
By Prof Mu Koh, Royal Marsden NHS Foundation Trust (ICR) Primary prostate cancer is a heterogeneous disease in terms of disease aggressiveness and long-term outcomes. Many men who are diagnosed with prostate cancer will have indolent disease and die of other causes....
By Prof Jurgen Futterer & Prof Henkjan Huisman, RadboudUMC (RUN) Professors Jurgen Futterer and Henkjan Huisman are both affiliated with Radboudumc, Nijmegen, The Netherlands. They have a long-standing collaboration and are part of the EU H2020 project ProCAncer-I...
By Joao Correia, Innovation Manager at Biotronics3D Limited (B3D) The ProCAncer-I eCRF (electronic case report form) and Data Upload Tools support ProCAncer-I clinical partners in the process of compiling the required information and follow the defined protocols for...
By Theresa Henne, University of Vienna (UNIVIE), Clara Saillant University of Vienna (UNIVIE) &Varvara Kalokyri, Foundation for Research and Technology (FORTH) Data is increasingly regarded as a valuable resource, in particular for the development of Big Data and...
Biotronics3D was established in 2004 in London, opened an R&D Centre in Cambridge in 2009, opened a Central European Operations office in Bucharest in 2014, and established its Innovation Centre in Edinburgh during 2017. Biotronics3D recently integrated the...
The Girona Biomedical Research Institute (IDIBGI) aims to promote translational research to improve people's health. Located in Girona area, in Catalonia (Spain), its activity aims to increase knowledge of numerous diseases to improve their diagnosis, treatment and...
Newsletter #4 Contents
ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...
Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and ii) include...
ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...